Matt Maurer speaks to The Globe and Mail regarding the ongoing situation at CannTrust
Shares of CannTrust Holdings Inc. dropped 22 per cent on Wednesday, a day after The Globe and Mail reported both CannTrust’s chairman and chief executive officer were informed about cannabis being grown in parts of a facility that had not been licensed seven months before Health Canada uncovered the regulatory breach.
Matt Maurer, the vice-chairman of Toronto-based Torkin Manes LLP’s Cannabis Law Group, said he’s received a large number of calls from U.S. financial institutions over the past several days inquiring about the situation at CannTrust.
“It seems like these calls are more like, ‘should we be selling and should we be shorting?’ versus, ‘where should we be looking to buy at the low end?’ ” Mr. Maurer said, referring to the practice of short-selling, where investors bet on share price declines.
This article was originally published on The Globe and Mail website. To read the complete article, visit The Globe and Mail.
Most Recent Posts
It was the advice given many times to maiden pot users, emboldened by Canadian legalization to take their first tokes over the past year:
Oct 15, 2019
Torkin Manes is proud to sponsor the upcoming Queen's Law Alumni Event Cannabis in Canada - A Year in Review, taking place on October 17th.&...
Oct 11, 2019
Online grey market cannabis sellers are competing with the legal market by undercutting it and offering deep volume discounts, data rel...
Oct 9, 2019